(Q39722178)

14 September 2017

erbB receptor expression patterns in human bladder cancer (English)

1 reference

14 September 2017

Rajjayabun PH

1

1 reference

14 September 2017

Keegan PE

series ordinal

2

1 reference

14 September 2017

Lunec J

series ordinal

3

1 reference

14 September 2017

Mellon JK

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

14 September 2017

1 reference

14 September 2017

66

1 reference

14 September 2017

196-200

1 reference

14 September 2017

1

1 reference

Superficial bladder cancer: progression and recurrence

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

The significance of lamina propria invasion on the prognosis of patients with bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

The protein tyrosine kinase family of the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Epidermal growth factor receptor expression, proliferation, and colony stimulating activity production in the urinary bladder carcinoma cell line 5637.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

Future options with trastuzumab for primary systemic and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.046

10.1016/J.UROLOGY.2005.01.046

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference